Skip to main content
Industry article

Eppendorf Breaks Ground on a EUR 40 Million Production Site in Penang, Malaysia

On 12 November 2026, Eppendorf SE broke ground on a new production facility at Bandar Cassia Technology Park in Penang. The EUR 40 million investment is the company's first manufacturing operation in Southeast Asia and will produce selected products from its Centrifuges & Instruments portfolio for laboratories worldwide, with production starting gradually in 2028.

Eppendorf Breaks Ground on a EUR 40 Million Production Site in Penang, Malaysia

A first manufacturing site in Southeast Asia

Eppendorf SE has marked the start of construction on its new production facility at Bandar Cassia Technology Park in Penang, Malaysia. The groundbreaking ceremony on 12 November 2026 is a major step in the company's expansion in Malaysia and establishes its first manufacturing operation in Southeast Asia.

The EUR 40 million investment extends Eppendorf's global manufacturing network with production capability for selected products from its Centrifuges & Instruments portfolio. The products are intended for laboratories and scientific workplaces worldwide.

The site will join Eppendorf's global manufacturing and quality framework, applying the company's expectations for quality, process reliability, compliance and operational excellence.

Building a more resilient production network

"Today's groundbreaking is further evidence of the consistent implementation of Eppendorf's corporate strategy, through which we continue to strengthen our innovative capabilities and make our global production capacity more resilient," said Dr. Christine Munz, CEO of the Eppendorf Group.

"This site is a strong commitment to Malaysia and will be an important new pillar in Eppendorf's global manufacturing network. It will strengthen the competitiveness and flexibility of our Centrifuges & Instruments business."

Integrated manufacturing planned for quality and growth

The site covers approximately 48,500 square metres and is planned to have a total built-up area of around 16,000 square metres. Production, warehousing, offices, quality-related functions, shipping and logistics areas, and employee facilities will be brought together in a single, integrated manufacturing environment.

Production is expected to begin gradually in 2028, followed by a structured ramp-up through 2030. Individual product lines will be qualified and brought into operation step by step, supporting quality, operational stability and continuity of supply.

Eppendorf anticipates around 130 employees at the site by the end of 2029.

Key figures

Investment: EUR 40 million.

Location: Bandar Cassia Technology Park, Penang, Malaysia.

Site area: approximately 48,500 square metres, with around 16,000 square metres built up.

Products: selected centrifuges and instruments for laboratories worldwide.

Timeline: production begins gradually in 2028, with a structured ramp-up through 2030.

Jobs: around 130 employees by the end of 2029.

Three decades in Malaysia

Eppendorf has been present in Malaysia for more than three decades, beginning with an office in Kuala Lumpur in 1995. The Penang investment extends the company's established commercial and administrative presence into manufacturing.

It also adds a Southeast Asian location to a production footprint that has historically been centred in Europe and the United States.

The Connexius perspective

Eppendorf's decision reflects a wider pattern: global life science suppliers are adding production in Southeast Asia to make their supply chains more resilient and to sit closer to the region's growing base of laboratories, biomanufacturers and research institutions.

Penang already has a deep manufacturing ecosystem, and a new instruments plant adds to Malaysia's ambition to move up the life science value chain. For biopharma companies in the region, more local production of core laboratory equipment can support continuity of supply as Southeast Asia's biologics and vaccine capacity expands.

These supply chain and manufacturing questions will be discussed at Connexius Biologics SEA 2027 in Ho Chi Minh City on 20–21 October 2027, which brings together biopharma manufacturers, CDMOs and technology providers from across Southeast Asia.

Frequently asked questions

Where is Eppendorf's new Malaysian production site?
The site is at Bandar Cassia Technology Park in Penang, Malaysia. Construction started with a groundbreaking ceremony on 12 November 2026.
How much is Eppendorf investing in Penang?
Eppendorf is investing EUR 40 million in the facility, its first manufacturing operation in Southeast Asia.
What will the Penang site produce?
It will produce selected products from Eppendorf's Centrifuges & Instruments portfolio, intended for laboratories and scientific workplaces worldwide.
When will production start?
Production is expected to begin gradually in 2028, with a structured ramp-up through 2030. Eppendorf expects around 130 employees at the site by the end of 2029.

WHERE THIS CONVERSATION CONTINUES

Join the leaders shaping this market at an upcoming Connexius conference.